Related Experiment Video
Updated: May 5, 2026

07:45
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
2.6K
Activated lymphocytes as a metabolic model for carcinogenesis
Andrew N Macintyre1, Jeffrey C Rathmell
1Department of Pharmacology and Cancer Biology, Department of Immunology, Sarah W, Stedman Nutrition and Metabolism Center, Duke University, Durham, NC, 27710, USA. jeff.rathmell@duke.edu.
Cancer & Metabolism
|November 28, 2013
Summary
Cancer cells and activated T cells share metabolic reprogramming, relying on glycolysis and glutamine. Studying T cells offers insights into tumor metabolism and potential therapeutic targets.
Area of Science:
- Immunology
- Cancer Biology
- Metabolic Research
Background:
- Cancer cells exhibit metabolic reprogramming, favoring glycolysis and glutamine dependency for growth.
- Activated T lymphocytes (T cells) also undergo metabolic shifts, adopting similar glycolytic and glutamine-dependent pathways.
- These metabolic changes in both cell types support proliferation and survival.
Purpose of the Study:
- To review metabolic similarities and differences between activated T cells and cancer cells.
- To discuss common signaling pathways and regulators driving metabolic rewiring.
- To explore therapeutic strategies targeting shared metabolic vulnerabilities.
Main Methods:
- Literature review of metabolic reprogramming in cancer and T cells.
- Comparative analysis of metabolic pathways and regulatory mechanisms.
- Discussion of signaling pathways and master metabolic regulators.
Main Results:
- Activated T cells and cancer cells share key metabolic reprogramming mechanisms, including increased glycolysis and glutamine utilization.
- Similar signaling pathways and master regulators govern metabolic rewiring in both contexts.
- Metabolic adaptations confer survival and growth advantages in both activated T cells and cancer cells.
Conclusions:
- Activated T cells serve as a valuable model for understanding tumor metabolism due to shared metabolic reprogramming.
- Identifying common metabolic regulators may lead to novel therapeutic strategies targeting cancer metabolism.
- Understanding T cell metabolism can inform approaches to modulate immune responses and target inflammatory processes.

